My bias is in favor of the story and potential that’s pretty plain to see. This is no longer Chris Nelson’s show. His interest is largely from debt conversion and amounts to 4.9%. Other management and insiders own just over 53.5% of the company.
It seems to me he’s made connections with some pretty successful people and provided himself and other investors with a remarkable opportunity.
What do we know?
1. Management has a track record of success. Check out co-founders Douglas Baum and C.Richard Piazza’s bios. Then look up Link, Sugarman, Frank, and Simon. What’s not to love?
Just check out their website. https://qsambio.com/
Then compare the management/ insider ownership here: https://www.otcmarkets.com/filing/html?id=15429489&guid=OhvwkaoGobwyOth
2. Venture capitalists have been willing to commit substantial resources to the future success of the company. I've not added up the totals but I think it's between $3 and 5$ Million.
3. We have an actual drug with a proven history of effective treatment of bone cancer.
4. We have a drug in Phase 1 FDA Trial… that is really an improved drug with fewer side effects.
5. The value of the company surpasses the current drug candidate. QSAM has an exclusive license agreement on any future drugs or treatment protocols developed by IGL Pharma, Inc, the maker or developer of Samarium-153 DOTMP, known as CycliSam.
Will all this end with success or failure? Time will tell.
Watch for opportunities with those you trust.
Recent QSAM News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 10:19:46 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:51:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:09:38 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 02:51:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:56:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:08:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:43:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:51:16 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM